HEDIS 2008 Final NDC Lists
NOTE:  All medications appearing in the 2008 Final NDC Lists have been verified by industry experts. This year’s lists include a link to the measure’s NDC list in Excel format as well as a link to the respective drug table from Volume 2 in Word format. Regional and Proprietary NDC codes should be mapped to the NDC list using generic name, dosage and route. Further clarification on mapping can be found in the Volume 2 Technical Specifications (General Guideline #54, page 35).

2008 NDC LISTS

 

Chlamydia Screening in Women (CHL)Denominator.xls | Table CHL-A.doc

Follow-up Care for Children Prescribed ADHD Medication (ADD)

ADD Medications.xls | Table ADD-A.doc

Chlamydia Screening in Women (CHL)

Exclusions.xls

Annual Monitoring for Patients on Persistent Medications (MPM)

 Digoxin.xls | Table MPM-B.doc

Appropriate Testing for Children with Pharyngitis (CWP) 

Denominator.xls | Table CWP-C.doc

Annual Monitoring for Patients on Persistent Medications (MPM)

Diuretic.xls | Table MPM-C.doc

Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis (AAB)

Numerator.xls | Table AAB-D.doc

Annual Monitoring for Patients on Persistent Medications (MPM)

 Anticonvulsants.xls | Table MPM-D.doc

Pharmacotherapy Management of COPD Exacerbation (PCE)

Systemic Corticosteroids.xls | Table PCE-C.doc

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)

Tricyclic Antidepressants.xls | Table DDE-C.doc

Pharmacotherapy Management of COPD Exacerbation (PCE)

Bronchodilators.xls | Table PCE-D.doc

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)

Antipsychotics & Sleep Agents.xls | Table DDE-D.doc

Use of Appropriate Medications for People with Asthma (ASM)

Denominator.xlsTable ASM-C.doc

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)

Dementia.xls | Table DDE-F.doc

Use of Appropriate Medications for People with Asthma (ASM)

Numerator.xls | Table ASM-D.doc

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)

Anticholinergic.xls | Table DDE-G.doc

Persistence of Beta-Blocker Treatment After a Heart Attack (PBH)

Numerator.xlsTable PBH-B.doc

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)

NSAIDS and COX-2s.xls | Table DDE-I.doc

Persistence of Beta-Blocker Treatment After a Heart Attack (PBH)

Exclusions.xls | Table PBH-C.doc

Use of High Risk Medications in the Elderly (DAE)

Numerator.xls | Table DAE-A.doc

Comprehensive Diabetes Care (CDC)

Denominator.xlsTable CDC-A.doc

Antibiotic Utilization (ABX)

Antibiotic Medications.xls | Table ABX-A.doc

Comprehensive Diabetes Care (CDC) 

ACE/ARBs.xls | Table CDC-L.doc

Antibiotic Utilization (ABX)

Of Concern.xls | Table ABX-B.doc

Disease Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis (ART)

Numerator.xlsTable ART-C.doc

Antibiotic Utilization (ABX)

All Others.xls | Table ABX-C.doc

Osteoporosis Management in Women who had a Fracture (OMW)

Numerator.xlsTable OMW-C.doc

Antidepressant Medication Management (AMM)

AMM Medications.xls | Table AMM-D.doc

 

 NDC Final List (.zip)

 

 

If you have difficulty downloading these files, please contact NCQA's Customer Service Center at (888) 275-7585.
© Copyright 2008, NCQA. All Rights Reserved.
National Committee for Quality Assurance     1100 13th Street, NW, Suite 1000, Washington, DC 20005
Telephone: 202/955-3500 | Fax: 202/955-3599 | Customer Support: 888/275-7585